trial · primary record
leukapheresis
Diffuse Large B-cell Lymphoma (DLBCL)
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 59 |
| Primary completion | 2026-10 |
| Primary endpoint | progression-free survival (PFS) |
| Registry ID | NCT02570542 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:24.884Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02570542
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.